Induction of differentiation of leukaemic (HL-60) or prostate cancer (LNCaP, JCA-1) cells potentiates apoptosis triggered by onconase

Cell Proliferation

Volumn 33, Issue 6, 2000, Pages 407-417

  Halicka, H D ^a   Murakami, T ^a   Papageorgio, C N ^a   Mittelman, A ^b   Mikulski, S M ^c   Shogen, K ^c   Darzynkiewicz, Z ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Zalman Arlin Cancer Institute   (United States)

^c Alfacell Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLBUTYRIC ACID DERIVATIVE; BUTYRIC ACID; DIMETHYL SULFOXIDE; RANPIRNASE; RETINOIC ACID; RIBONUCLEASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; PROSTATE CANCER;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BUTYRATES; CELL DIFFERENTIATION; DIMETHYL SULFOXIDE; DNA; DRUG SYNERGISM; EGG PROTEINS; HL-60 CELLS; HUMANS; MALE; PHENYLBUTYRATES; PROSTATIC NEOPLASMS; RIBONUCLEASES; RNA; TRETINOIN; TUMOR CELLS, CULTURED;

AMPHIBIA; ANIMALIA;

EID: 0033678736     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2184.2000.00186.x     Document Type: Article

References (44)

1. Tumor growth inhibition, apoptosis and Bcl-2 down- regulation of MCF-7 ras tumors by sodium phenylacetate and tamoxifen combination
2. Enzymatic characterization of onconase, a novel ribonuclease with anti-tumor activity
3. Amino acid sequence of an anti-tumor protein from Rana pipiens oocytes and early embryos. Homology to pancreatic ribonuclease
4. Interaction beteen dexamethasone and butyrate in apoptosis induction: Non-additive in thymocytes and synergistic in a T-cell derived leukemia line
5. Induction of cell differentiation potentiates apoptosis triggered by prior exposure to DNA damaging drugs
6. Role of N terminus in RNase A homologues: Differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity
7. Cancer cell sensitization to Fas-mediated apoptosis by sodium butyrate
8. The use of ONCONASE (ONC) for patients (PTS) with advanced mesothelioma (MM)
9. Simultaneous analysis of cellular RNA and DNA content
10. Cytostatic and cytotoxic effects of Pannon (P-30 Protein), a novel anticancer agent
11. Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis)
12. Effect of n-butyrate on cell cycle and in situ chromatin structure of L1210 cells
13. Altered susceptibility of differentiating HL-60 cells to apoptosis induced by antitumor drugs
14. Potentiation of tumor necrosis factor induced apoptosis by onconase
15. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry
16. DNA strand breaks occuring during apoptosis: Their in situ detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors
17. Enhanced apoptosis in leukemia cells following treatment with combination fluoropyrimidines and differentiation inducers
18. Enhanced growth inhibition and differentiation of fluorodeoxyuridine-treated human colon carcinoma cells by phenylbutyrate
19. 1 arrest of U937 cells by onconase is associated with suppression of cyclin D3 expression, induction of p16(INK4A), P21(WAF1/CIP1) and p27 and decreased pRb phosphorylation
20. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to Bcl2
21. Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family
22. Characterization of the mechanism of cellular and cell free protein synthesis inhibition by an anti-tumor ribonuclease
23. Regulation by bcl-2, c-myc, and p53 of sussceptibiliy to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation- competent and -defective leukemic cells
24. Chromatin remodeling and transcriptional regulation
25. 2+ -dependent endonuclease activity during the early stages of murine erythroleukemia cell differentiation
26. Striking increase in survival of mice bearing M109 Madison carcinoma treated with a novel protein from amphibian embryos
27. Relationship between response rate and median survival in patients with advanced non-small cell lung cancer: Comparison of ONCONASE with other anticancer agents
28. Tamoxifen and trifluoroperazine (Stelazine) potentiate cytotostatic/cytotoxic effects of P-30 Protein, a novel protein possesing anti-tumor activity
29. Synergism between a novel amphibian oocyte ribonuclease and lovastatin in inducing cytostatic and cytotoxic effects in human lung and pancreatic carcinoma cell lines
30. Enhanced in vitro cytotoxicity and cytostasis of the combination of onconase with a proteasome inhibitor
31. In vitro synergism between a novel amphibian oocytic ribonuclease (ONCONASE) and tamoxifen, lovastatin and cisplatin in human OVCAR-3 ovarian carcinoma cell line
32. Refined 1.7 A X-ray crystallographic structure of P-30 protein, an amphibian ribonuclease with antitumor activity
33. Natural and engineered cytotoxic ribonucleases: Therapeutic potential
34. Cytotoxic onconase and ribonuclease A chimeras: Comparison and in vitro characteristics
35. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with ONCONASE, an antitumor ribonuclease
36. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors
37. 3 of cytotoxicity to HL-60 cells produced by cytarabine and hydroxyurea
38. Histone acetylation: Chromatin in action
39. 3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced cytochrome c
40. Granulocytic differentiation of HL-60 cells results in spontaneous apoptosis mediated by increased caspase expression
41. Enhancement of differentiation and cytotoxicity of leukemia cells by combinations of fluorinated pyrimidines and differentiation inducers: Development of DNA double-strand breaks
42. A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity
43. A study of the intracellular routing of cytotoxic ribonucleases
44. 3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene